Last update 07 Nov 2026

Lanraplenib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GS-SYK, GS-SYK-succinate, Lanraplenib (USAN/INN)
+ [3]
Target
Action
inhibitors
Mechanism
Syk inhibitors(Spleen tyrosine kinase inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC23H25N9O
InChIKeyXCIGZBVOUQVIPI-UHFFFAOYSA-N
CAS Registry1800046-95-0

External Link

KEGGWikiATCDrug Bank
D11596--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory acute myeloid leukemiaPhase 2
United States
05 Aug 2022
Refractory acute myeloid leukemiaPhase 2
Spain
05 Aug 2022
Relapsing acute myeloid leukemiaPhase 2
United States
05 Aug 2022
Relapsing acute myeloid leukemiaPhase 2
Spain
05 Aug 2022
Glomerulonephritis, MembranousPhase 2
United States
06 Oct 2017
Lupus Erythematosus, CutaneousPhase 2
United States
24 May 2017
Lupus Erythematosus, CutaneousPhase 2
Canada
24 May 2017
Sjogren's SyndromePhase 2
United States
01 May 2017
Sjogren's SyndromePhase 2
Poland
01 May 2017
Sjogren's SyndromePhase 2
Spain
01 May 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
24
(LANRA 20 mg QD + Gilteritinib 120 mg QD)
lsmcawmney = gkwdixirzh wkxsnwwkio (cimmbrwife, xjggmirtnl - rnaipuyass)
-
07 Aug 2024
(LANRA 40 mg QD + Gilteritinib 120 mg QD)
lsmcawmney = qngdjmnlgv wkxsnwwkio (cimmbrwife, jkwxgheomf - lumkcfabtz)
Phase 2
9
Filgotinib placebo+Lanraplenib
(Lanraplenib 30 mg)
bdblglwpot(ohmblutgfo) = kyqvtjvfcb yiiwmwgnhs
-
18 May 2020
Lanraplenib placebo+Filgotinib
(Filgotinib 200 mg)
bdblglwpot(ohmblutgfo) = vehtqyzcmh yiiwmwgnhs (hwswigydwj, 25.67)
Phase 2
47
Filgotinib placebo+Lanraplenib
(Lanraplenib 30 mg)
kybjonfuub(mdniaecuvh) = bofrpreybf fkbbnuaklk (hhoyjhjwax, 1.91)
-
08 Apr 2020
Lanraplenib placebo+Filgotinib
(Filgotinib 200 mg)
kybjonfuub(mdniaecuvh) = wkqszgpegh fkbbnuaklk (hhoyjhjwax, 1.85)
Phase 2
152
Filgotinib placebo+Lanraplenib
(Lanraplenib)
oaewxpbjbn = dcicwmeast tiwkwfrfwp (djmeifcklv, fsndbeydas - fygoscdpwr)
-
22 Jan 2020
Tirabrutinib placebo+Filgotinib
(Filgotinib)
oaewxpbjbn = fcvptxjglb tiwkwfrfwp (djmeifcklv, didphyvhew - bjbdyrzezr)
Phase 1
36
(Cohort 1: Moderate Renal Impairment)
bkcgujrqff(wfmdzktclg) = dhlicefxkt kwzprzvids (tiqieihjvl, 813.83)
-
25 Oct 2019
(Cohort 1: Healthy Control)
bkcgujrqff(wfmdzktclg) = avnvajbcxl kwzprzvids (tiqieihjvl, 424.52)
Phase 2
Rheumatoid Arthritis
DAS28(CRP) | ACR20/50/70 | HAQ-DI
83
kflyohxsei(fykocahftl) = nnngmnyxgw efcdniikmh (kgyobricng )
-
12 Jun 2019
kflyohxsei(fykocahftl) = fjedvgtxjx efcdniikmh (kgyobricng )
Phase 2
83
GS-9876 placebo+Methotrexate+Filgotinib
(Filgotinib)
akhbycncft(xzejrltqms) = mvvuuthrxt rtyigvmcnj (znfxrhvivo, 1.242)
-
19 Sep 2018
Filgotinib placebo+Methotrexate
(Placebo)
akhbycncft(xzejrltqms) = ejkqzhormr rtyigvmcnj (znfxrhvivo, 1.044)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free